JP5026405B2 - 短針を有する注射器のための充填システムおよび方法 - Google Patents
短針を有する注射器のための充填システムおよび方法 Download PDFInfo
- Publication number
- JP5026405B2 JP5026405B2 JP2008501979A JP2008501979A JP5026405B2 JP 5026405 B2 JP5026405 B2 JP 5026405B2 JP 2008501979 A JP2008501979 A JP 2008501979A JP 2008501979 A JP2008501979 A JP 2008501979A JP 5026405 B2 JP5026405 B2 JP 5026405B2
- Authority
- JP
- Japan
- Prior art keywords
- delivery device
- shield
- needle
- septum
- adapter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 19
- 239000003814 drug Substances 0.000 claims abstract description 52
- 229940079593 drug Drugs 0.000 claims abstract description 50
- 239000000126 substance Substances 0.000 claims description 29
- 239000012530 fluid Substances 0.000 claims description 22
- 238000004891 communication Methods 0.000 claims description 18
- 230000007246 mechanism Effects 0.000 claims description 8
- 238000004873 anchoring Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims 1
- 230000035515 penetration Effects 0.000 abstract description 9
- 238000002347 injection Methods 0.000 description 37
- 239000007924 injection Substances 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 29
- 229940088679 drug related substance Drugs 0.000 description 11
- 239000008186 active pharmaceutical agent Substances 0.000 description 10
- 210000000078 claw Anatomy 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 238000005192 partition Methods 0.000 description 9
- -1 vaccines Substances 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 241001442495 Mantophasmatodea Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 241000816129 Alcha Species 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000001718 Immediate Hypersensitivity Diseases 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 206010045240 Type I hypersensitivity Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- 229940124433 antimigraine drug Drugs 0.000 description 2
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000000734 parasympathomimetic agent Substances 0.000 description 2
- 230000001499 parasympathomimetic effect Effects 0.000 description 2
- 229940005542 parasympathomimetics Drugs 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000022497 Cocaine-Related disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 1
- 229940122853 Growth hormone antagonist Drugs 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010093625 Opioid Peptides Proteins 0.000 description 1
- 102000001490 Opioid Peptides Human genes 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 102100022831 Somatoliberin Human genes 0.000 description 1
- 101710142969 Somatoliberin Proteins 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000000648 anti-parkinson Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940124347 antiarthritic drug Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 108010055460 bivalirudin Proteins 0.000 description 1
- 229960001500 bivalirudin Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960001113 butorphanol Drugs 0.000 description 1
- IFKLAQQSCNILHL-QHAWAJNXSA-N butorphanol Chemical compound N1([C@@H]2CC3=CC=C(C=C3[C@@]3([C@]2(CCCC3)O)CC1)O)CC1CCC1 IFKLAQQSCNILHL-QHAWAJNXSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 201000006145 ***e dependence Diseases 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003241 dermatological agent Substances 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
- 229960004704 dihydroergotamine Drugs 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229940052760 dopamine agonists Drugs 0.000 description 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 description 1
- 229960003727 granisetron Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 201000010284 hepatitis E Diseases 0.000 description 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 description 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000003055 low molecular weight heparin Substances 0.000 description 1
- 229940127215 low-molecular weight heparin Drugs 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229960005343 ondansetron Drugs 0.000 description 1
- 239000003399 opiate peptide Substances 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002089 prostaglandin antagonist Substances 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000952 serotonin receptor agonist Substances 0.000 description 1
- 229960003310 sildenafil Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/04—Access sites having pierceable self-sealing members
- A61M2039/042—Shrouds encircling the access needle preventing accidental needle-stick
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/1782—Devices aiding filling of syringes in situ
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Telephone Function (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
Claims (18)
- 所定の厚さの隔壁を有する薬剤コンテナから、医療用物質を送達デバイス中に移送するのに使用するための液移送システムであって、
医療用物質を保管するように適合された前記送達デバイス内の貯蔵部と、
前記貯蔵部と流体連通する管腔を有し、また患者への皮内送達に適合して事前に選択された使用可能な長さにわたり前記送達デバイスから離間側に延びる前方先端部を有する、前記送達デバイスに取り付けられた針カニューレであって、前記使用可能な長さは、3mm未満且つ前記コンテナの前記隔壁の厚さ未満である針カニューレと、
アダプタ本体であって、
隔壁アクセス針を有するコンテナ受入れ部分と、
前記アダプタから延びる長手方向の突き出しを含むバイアルアダプタの突出し部であって、厚さを有するアダプタ隔壁および遠位部分を含んでおり、前記アダプタ隔壁の前記厚さは、前記針カニューレの使用可能な長さ未満であり、また前記遠位部分は、前記隔壁アクセス針の管腔と流体連通している突出し部と
を含むアダプタ本体とを備え、
前記コンテナが前記コンテナ受入れ部分中に受け入れられ、かつ前記送達デバイス針が前記アダプタ隔壁を貫通したとき、前記コンテナ中の前記物質と、前記送達デバイスの前記貯蔵部の間で流体連通が確立されることを特徴とする液移送システム。 - 少なくとも第1の位置および第2の位置を有する、前記送達デバイス上に摺動可能に配置されたシールドであって、前記第1の位置は、前記針カニューレの前記前方先端部を露出し、前記第2の位置は、前記針カニューレの前記前方先端部を隠すシールドをさらに備えることを特徴とする請求項1に記載のシステム。
- 前記シールドは、少なくとも1つのスロットを含み、前記スロットは、前記バイアルアダプタの突出し部上の対応する機構と協動し、前記協動により、前記送達デバイスを前記バイアルアダプタ本体に取外し可能に取り付けることができることを特徴とする請求項2に記載のシステム。
- 前記バイアルアダプタの突出し部は、前記シールド中の前記スロットにより受け入れられる少なくとも1つの固定フィンガを含むことを特徴とする請求項3に記載のシステム。
- 前記バイアルアダプタの突出し部は、前記送達デバイス上に配置された対応するレセプタクルにより受け入れられる少なくとも1つの突起を含むことを特徴とする請求項1に記載のシステム。
- 前記バイアルアダプタの突出し部は、前記送達デバイス上に配置された少なくとも1つの爪を受け入れるように適合された少なくとも1つのレセプタクルを含むことを特徴とする請求項1に記載のシステム。
- 前記バイアルアダプタの突出し部の少なくとも1つの突起は、螺旋パターンで形成されることを特徴とする請求項5に記載のシステム。
- 前記バイアルアダプタの突出し部のレセプタクルは、螺旋パターンで形成されることを特徴とする請求項6に記載のシステム。
- 前記シールドは、前記シールドが前記第2の位置にあるとき、少なくとも1つの停止部と係合するキャッチを含み、それにより、前記シールドが、前記第2の位置から前記第1の位置に移動するのを阻止することを特徴とする請求項2に記載のシステム。
- 前記アダプタ隔壁は、前記アダプタの突出し部の遠位部分に位置することを特徴とする請求項1に記載のシステム。
- 前記アダプタ隔壁は、前記アダプタの突出し部の近位部分に位置することを特徴とする請求項1に記載のシステム。
- 少なくとも第1の位置および第2の位置を有する、前記送達デバイス上に摺動可能に配置されたシールドであって、前記第1の位置は、前記針カニューレの前記前方先端部を隠し、前記第2の位置は、前記針カニューレの前記前方先端部を露出するシールドをさらに備えることを特徴とする請求項11に記載のシステム。
- 少なくとも第1の位置および第2の位置を有し、前記シールドと前記送達デバイスの間に摺動可能に配置された固定クリップであって、前記第1の位置は、前記送達デバイスに対して、前記シールドの近位の移動を可能にし、前記第2の位置は、前記送達デバイスに対して、前記シールドの近位の移動を阻止する固定クリップをさらに備えることを特徴とする請求項12に記載のシステム。
- 前記送達デバイスに対する前記シールドの、前記第2のシールド位置への第1の近位の移動が前記固定クリップを係合させ、かつ前記固定クリップを、前記固定クリップの前記第2の位置に移動させて、それにより、送達デバイスに対する前記シールドの近位の移動が阻止されることを特徴とする請求項13に記載のシステム。
- 患者への皮内送達に適合して事前に選択された使用可能な長さにわたり送達デバイスから離間側に延びる前方先端部を有する、前記送達デバイスに取り付けられた針カニューレと流体連通する貯蔵部を有する前記送達デバイス中に、所定の厚さを備える隔壁を有する薬剤コンテナから医療用物質を移送する方法であって、前記使用可能な長さは3mm未満且つ前記コンテナ隔壁の前記所定の厚さ未満であり、
前記針カニューレの使用可能な長さに満たない厚さを有するアダプタ隔壁の遠位部分と流体連通する管腔を有する隔壁アクセス針を含むアダプタを提供するステップと、
前記隔壁アクセス針で前記薬剤コンテナの隔壁を貫通するステップであって、前記コンテナの隔壁が前記隔壁アクセス針で貫通されたとき、前記医療用物質と前記管腔の間で流体連通が生ずるステップと、
前記送達デバイス針で前記アダプタ隔壁を貫通するステップであって、前記アダプタ隔壁が前記送達デバイス針で貫通されたとき、前記医療用物質と前記管腔の間で流体連通が生じ、それにより、前記コンテナ中の前記物質と前記送達デバイスの前記貯蔵部との間で流体連通が確立されるステップと、
前記医療用物質を前記送達デバイス中に吸引するステップと
を含むことを特徴とする方法。 - 前記送達デバイス針を針シールドでシールドするステップであって、それにより、前記針カニューレの前記前方先端部を隠し、前記シールドは、前記送達デバイスに摺動可能に係合するステップをさらに含むことを特徴とする請求項15に記載の方法。
- 送達デバイスであって、
医療用物質を保管するように適合された前記送達デバイス内の貯蔵部と、
前記貯蔵部と流体連通する管腔を有し、また事前に選択された使用可能な長さだけ前記送達デバイスから離れて延びる前方先端部を有する、前記送達デバイスに取り付けられた針カニューレと、
少なくとも第1の位置および第2の位置を有し、前記送達デバイス上に摺動可能に配置されたシールドであって、前記第1の位置は、前記針カニューレの前記前方先端部を隠し、かつ前記第2の位置は、前記針カニューレの前記前方先端部を露出するシールドと、
前記シールドと前記送達デバイスの間に摺動可能に配置され、少なくとも第1の位置および第2の位置を有する固定クリップであって、前記第1の位置は、前記送達デバイスに対して前記シールドの近位の移動を可能にし、かつ前記第2の位置は、前記送達デバイスに対して、前記シールドの近位の移動を阻止し、前記送達デバイスに対する前記シールドの、前記第2のシールド位置への第1の近位の移動が前記固定クリップを係合させ、かつ前記固定クリップを前記固定クリップの前記第2の位置に移動させて、それにより、前記送達デバイスに対する前記シールドの、その後の近位の移動を阻止する固定クリップと
を備えることを特徴とする送達デバイス。 - 前記シールドは、少なくとも1つのスロットを含み、前記スロットは、薬剤バイアルの突出し部上の対応する機構と協動し、前記協動により、前記送達デバイスの前記バイアルへの取外し可能な取付けを可能にすることを特徴とする請求項17に記載の送達デバイス。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66136705P | 2005-03-14 | 2005-03-14 | |
US60/661,367 | 2005-03-14 | ||
US11/374,488 US20070060904A1 (en) | 2005-03-14 | 2006-03-13 | Filling system and method for syringes with short needles |
US11/374,488 | 2006-03-13 | ||
PCT/US2006/009198 WO2006099441A2 (en) | 2005-03-14 | 2006-03-14 | Filling system and method for syringes with short needles |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008532701A JP2008532701A (ja) | 2008-08-21 |
JP5026405B2 true JP5026405B2 (ja) | 2012-09-12 |
Family
ID=36678529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008501979A Active JP5026405B2 (ja) | 2005-03-14 | 2006-03-14 | 短針を有する注射器のための充填システムおよび方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US20070060904A1 (ja) |
EP (1) | EP1858474B1 (ja) |
JP (1) | JP5026405B2 (ja) |
AT (1) | ATE489066T1 (ja) |
AU (1) | AU2006223047B2 (ja) |
BR (1) | BRPI0609008B8 (ja) |
CA (1) | CA2600590C (ja) |
DE (1) | DE602006018426D1 (ja) |
MX (1) | MX2007011239A (ja) |
WO (1) | WO2006099441A2 (ja) |
Families Citing this family (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL114960A0 (en) | 1995-03-20 | 1995-12-08 | Medimop Medical Projects Ltd | Flow control device |
US6989891B2 (en) | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
IL161660A0 (en) | 2004-04-29 | 2004-09-27 | Medimop Medical Projects Ltd | Liquid drug delivery device |
GB2414402B (en) | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
GB2414409B (en) | 2004-05-28 | 2009-11-18 | Cilag Ag Int | Injection device |
GB2414406B (en) | 2004-05-28 | 2009-03-18 | Cilag Ag Int | Injection device |
GB2414403B (en) | 2004-05-28 | 2009-01-07 | Cilag Ag Int | Injection device |
GB2414400B (en) | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414775B (en) | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
GB2414401B (en) | 2004-05-28 | 2009-06-17 | Cilag Ag Int | Injection device |
GB2414399B (en) | 2004-05-28 | 2008-12-31 | Cilag Ag Int | Injection device |
GB2424836B (en) | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
GB2424838B (en) | 2005-04-06 | 2011-02-23 | Cilag Ag Int | Injection device (adaptable drive) |
GB2425062B (en) | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
GB2424835B (en) | 2005-04-06 | 2010-06-09 | Cilag Ag Int | Injection device (modified trigger) |
GB2427826B (en) | 2005-04-06 | 2010-08-25 | Cilag Ag Int | Injection device comprising a locking mechanism associated with integrally formed biasing means |
ES2371557T3 (es) * | 2005-08-11 | 2012-01-05 | Medimop Medical Projects Ltd. | Dispositivos de transferencia de fármacos líquidos para un correcto ajuste a presión a prueba de fallos en viales medicinales. |
DK1759729T3 (da) | 2005-08-30 | 2010-04-19 | Cilag Gmbh Int | Nåleindretning til en forfyldt sprøjte |
US20110098656A1 (en) | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
US9295790B2 (en) * | 2006-05-05 | 2016-03-29 | Retractable Technologies, Inc. | Syringe with recessed nose and protective guard for use with frontal attachments |
CN101478946B (zh) | 2006-05-25 | 2013-11-06 | 拜耳医药保健有限公司 | 重构装置 |
GB2438590B (en) | 2006-06-01 | 2011-02-09 | Cilag Gmbh Int | Injection device |
GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
GB2438591B (en) | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
US8221363B2 (en) * | 2006-10-18 | 2012-07-17 | Baxter Healthcare S.A. | Luer activated device with valve element under tension |
US20080097407A1 (en) * | 2006-10-18 | 2008-04-24 | Michael Plishka | Luer activated device with compressible valve element |
US7981090B2 (en) * | 2006-10-18 | 2011-07-19 | Baxter International Inc. | Luer activated device |
US7753338B2 (en) | 2006-10-23 | 2010-07-13 | Baxter International Inc. | Luer activated device with minimal fluid displacement |
ITPD20060419A1 (it) | 2006-11-13 | 2008-05-14 | Federico Nalesso | Dispositivo per il trattamento manutentivo di cateteri venosi centrali |
US8002756B2 (en) | 2006-12-08 | 2011-08-23 | Becton, Dickinson And Company | Method and apparatus for delivering a therapeutic substance through an injection port |
IL182605A0 (en) | 2007-04-17 | 2007-07-24 | Medimop Medical Projects Ltd | Fluid control device with manually depressed actuator |
WO2008144575A2 (en) | 2007-05-18 | 2008-11-27 | Optiscan Biomedical Corporation | Fluid injection and safety system |
DE102007024539A1 (de) * | 2007-05-24 | 2008-11-27 | Fresenius Kabi Deutschland Gmbh | Verschlusskappe für ein Behältnis zur Aufnahme von Flüssigkeiten, insbesondere einer enteralen Nährlösung und Behältnis mit einer derartigen Verschlusskappe |
US8475404B2 (en) | 2007-08-21 | 2013-07-02 | Yukon Medical, Llc | Vial access and injection system |
JP2010538744A (ja) | 2007-09-18 | 2010-12-16 | メディモップ・メディカル・プロジェクツ・リミテッド | 薬剤混合注射装置 |
IL186290A0 (en) | 2007-09-25 | 2008-01-20 | Medimop Medical Projects Ltd | Liquid drug delivery devices for use with syringe having widened distal tip |
ES2585405T3 (es) * | 2008-01-09 | 2016-10-05 | Novartis Ag | Unidad de retirada de aguja unitaria adecuada para ajuste en fábrica |
JP5685522B2 (ja) * | 2008-04-01 | 2015-03-18 | ユーコン・メディカル,リミテッド・ライアビリティ・カンパニー | 複式容器用流体移送装置 |
GB2461086B (en) | 2008-06-19 | 2012-12-05 | Cilag Gmbh Int | Injection device |
US8398597B2 (en) * | 2008-06-17 | 2013-03-19 | Becton, Dickinson And Company | Needle shield and interlock |
GB2461089B (en) | 2008-06-19 | 2012-09-19 | Cilag Gmbh Int | Injection device |
GB2461084B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Fluid transfer assembly |
GB2461087B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
GB2461085B (en) | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
CA2742813C (en) * | 2008-11-07 | 2016-11-29 | Becton, Dickinson And Company | Syringe housing to facilitate medication injection |
JP5270424B2 (ja) * | 2009-03-30 | 2013-08-21 | テルモ株式会社 | 薬剤注射装置および注射針組立体 |
USD641080S1 (en) | 2009-03-31 | 2011-07-05 | Medimop Medical Projects Ltd. | Medical device having syringe port with locking mechanism |
USD616984S1 (en) * | 2009-07-02 | 2010-06-01 | Medimop Medical Projects Ltd. | Vial adapter having side windows |
AU2010300094B2 (en) | 2009-09-25 | 2013-06-27 | Ssb Technology Pty Ltd | Locking syringe system |
USD630732S1 (en) | 2009-09-29 | 2011-01-11 | Medimop Medical Projects Ltd. | Vial adapter with female connector |
IL201323A0 (en) | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
AU2010310457B2 (en) * | 2009-10-23 | 2015-07-02 | Amgen Inc. | Vial adapter and system |
CN102596145B (zh) * | 2009-10-30 | 2016-08-24 | 杜杰克特医疗***有限公司 | 瓶间转移*** |
IL202070A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
IL202069A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Fluid transfer device with sealing arrangement |
EP2512399B1 (en) | 2010-02-24 | 2015-04-08 | Medimop Medical Projects Ltd. | Fluid transfer assembly with venting arrangement |
CN102781396B (zh) * | 2010-02-24 | 2015-01-07 | 麦迪麦珀医疗工程有限公司 | 具备通气式瓶适配器的药液输送装置 |
WO2011111469A1 (ja) * | 2010-03-10 | 2011-09-15 | テルモ株式会社 | 注射針組立体及び薬剤注射装置 |
GB201005812D0 (en) * | 2010-04-07 | 2010-05-26 | Entpr Cradle The Ltd | Connector system for medical fluid administration |
US8333737B2 (en) | 2010-06-03 | 2012-12-18 | Jms North America Corporation | Systems and methods for a medical syringe |
USD655017S1 (en) | 2010-06-17 | 2012-02-28 | Yukon Medical, Llc | Shroud |
WO2012027280A2 (en) | 2010-08-22 | 2012-03-01 | St. John's Medical Research Institute, Inc. | Needle safety guard adapted to attach to a liquid container |
USD669980S1 (en) | 2010-10-15 | 2012-10-30 | Medimop Medical Projects Ltd. | Vented vial adapter |
IL209290A0 (en) | 2010-11-14 | 2011-01-31 | Medimop Medical Projects Ltd | Inline liquid drug medical device having rotary flow control member |
CA2817094C (en) * | 2010-11-15 | 2019-03-05 | Onpharma Inc. | Apparatus and methods for sequestering fluids exhausted during fluid transfer |
US9295788B2 (en) * | 2011-03-04 | 2016-03-29 | Anestaweb, Inc. | Syringe with integrated cannula |
US9480624B2 (en) | 2011-03-31 | 2016-11-01 | Amgen Inc. | Vial adapter and system |
IL212420A0 (en) | 2011-04-17 | 2011-06-30 | Medimop Medical Projects Ltd | Liquid drug transfer assembly |
JP5894582B2 (ja) | 2011-04-28 | 2016-03-30 | テルモ株式会社 | 注射針組立体及び薬剤注射装置 |
WO2012147408A1 (ja) | 2011-04-28 | 2012-11-01 | テルモ株式会社 | 注射針組立体及び薬剤注射装置 |
WO2012153563A1 (ja) * | 2011-05-10 | 2012-11-15 | テルモ株式会社 | 注射針組立体及び薬剤注射装置 |
FR2975896B1 (fr) * | 2011-06-06 | 2014-06-06 | Biocorp Rech Et Dev | Dispositif de connexion entre un recipient et un contenant, procede d'assemblage et d'utilisation d'un tel dispositif |
US9220660B2 (en) * | 2011-07-15 | 2015-12-29 | Antares Pharma, Inc. | Liquid-transfer adapter beveled spike |
USD681230S1 (en) | 2011-09-08 | 2013-04-30 | Yukon Medical, Llc | Shroud |
IL215699A0 (en) | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
IL217091A0 (en) * | 2011-12-19 | 2012-02-29 | Medimop Medical Projects Ltd | Vial adapter for use with syringe having widened distal syringe tip |
USD674088S1 (en) | 2012-02-13 | 2013-01-08 | Medimop Medical Projects Ltd. | Vial adapter |
USD720451S1 (en) | 2012-02-13 | 2014-12-30 | Medimop Medical Projects Ltd. | Liquid drug transfer assembly |
USD737436S1 (en) | 2012-02-13 | 2015-08-25 | Medimop Medical Projects Ltd. | Liquid drug reconstitution assembly |
IL219065A0 (en) | 2012-04-05 | 2012-07-31 | Medimop Medical Projects Ltd | Fluid transfer device with manual operated cartridge release arrangement |
USD769444S1 (en) | 2012-06-28 | 2016-10-18 | Yukon Medical, Llc | Adapter device |
IL221635A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Drug vial mixing and transfer device for use with iv bag and drug vial |
IL221634A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Universal drug vial adapter |
US9339438B2 (en) | 2012-09-13 | 2016-05-17 | Medimop Medical Projects Ltd. | Telescopic female drug vial adapter |
USD734868S1 (en) | 2012-11-27 | 2015-07-21 | Medimop Medical Projects Ltd. | Drug vial adapter with downwardly depending stopper |
US20140257204A1 (en) * | 2013-03-05 | 2014-09-11 | Stuart Robert Lessin | Apparatus for reconstituting and dispensing drugs for topical application |
IL225734A0 (en) | 2013-04-14 | 2013-09-30 | Medimop Medical Projects Ltd | A ready-to-use medicine vial device including a medicine vial closure, and a medicine vial closure for it |
CN110302004B (zh) | 2013-05-03 | 2023-04-28 | 科尼尔赛德生物医学公司 | 用于眼部注射的设备和方法 |
EP2983745B1 (en) | 2013-05-10 | 2018-07-11 | Medimop Medical Projects Ltd | Medical devices including vial adapter with inline dry drug module |
EP2803348A1 (de) * | 2013-05-15 | 2014-11-19 | hameln rds gmbh | Verfahren zur Befüllung von Spritzen für Dosierpumpen |
GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
US10688295B2 (en) | 2013-08-07 | 2020-06-23 | West Pharma. Services IL, Ltd. | Liquid transfer devices for use with infusion liquid containers |
USD767124S1 (en) | 2013-08-07 | 2016-09-20 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
USD765837S1 (en) | 2013-08-07 | 2016-09-06 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
USD757933S1 (en) | 2014-09-11 | 2016-05-31 | Medimop Medical Projects Ltd. | Dual vial adapter assemblage |
WO2016109847A1 (en) * | 2015-01-02 | 2016-07-07 | James Ankrum | Cross-linkable tissue bulking compositons |
US10285907B2 (en) | 2015-01-05 | 2019-05-14 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblages with quick release drug vial adapter for ensuring correct usage |
WO2016181826A1 (ja) * | 2015-05-14 | 2016-11-17 | ニプロ株式会社 | 薬剤投与具およびプレフィルドシリンジ |
WO2017009822A1 (en) | 2015-07-16 | 2017-01-19 | Medimop Medical Projects Ltd | Liquid drug transfer devices for secure telescopic snap fit on injection vials |
USD801522S1 (en) | 2015-11-09 | 2017-10-31 | Medimop Medical Projects Ltd. | Fluid transfer assembly |
US11234899B2 (en) | 2017-05-11 | 2022-02-01 | Scalpal Llc | Grasping facilitators and uses thereof and kits involving the same |
CN108366905A (zh) | 2015-11-25 | 2018-08-03 | 西部制药服务以色列有限公司 | 包括具有自动密封的入口阀的药瓶转接器的双瓶转接器组件 |
EP3181167B1 (en) | 2015-11-30 | 2023-01-11 | Becton, Dickinson and Company | Short injection length syringe |
US11648179B2 (en) | 2016-05-16 | 2023-05-16 | Haemonetics Corporation | Sealer-less plasma bottle and top for same |
CN109152698B (zh) | 2016-05-16 | 2022-07-01 | 美国血液技术公司 | 无密封件的血浆瓶及其顶盖 |
IL245800A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | A device with two vial adapters includes two identical vial adapters |
IL245803A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Devices with two vial adapters include an aerated drug vial adapter and an aerated liquid vial adapter |
IL246073A0 (en) | 2016-06-06 | 2016-08-31 | West Pharma Services Il Ltd | A fluid transport device for use with a slide-driven piston medicine pump cartridge |
IL247376A0 (en) | 2016-08-21 | 2016-12-29 | Medimop Medical Projects Ltd | Injector assembly |
USD832430S1 (en) | 2016-11-15 | 2018-10-30 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblage |
IL249408A0 (en) | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | A device for transporting fluids for use with an infusion fluid container and a hand tool similar to a plunger to release a vial from it |
US10918801B2 (en) * | 2016-12-13 | 2021-02-16 | Becton, Dickinson And Company | Caps for integrated fill and inject of safety needle devices |
IL251458A0 (en) | 2017-03-29 | 2017-06-29 | Medimop Medical Projects Ltd | Liquid drug delivery devices are user-operated for use in pre-prepared liquid drug delivery assemblies (rtu) |
US11969864B2 (en) | 2017-05-11 | 2024-04-30 | Scalpal Llc | Multi-tier torque enhancer driver and/or receiver and method of using same |
IL254802A0 (en) | 2017-09-29 | 2017-12-31 | Medimop Medical Projects Ltd | A device with two vial adapters includes two identical perforated vial adapters |
US11529467B2 (en) * | 2017-11-02 | 2022-12-20 | Hoffmann-La Roche Inc. | Container adapter, delivery assembly and method of delivering a liquid to a patient |
US11344715B2 (en) | 2018-01-26 | 2022-05-31 | Becton, Dickinson And Company | Flush syringe with disinfecting feature |
US11083847B2 (en) | 2018-01-26 | 2021-08-10 | Becton, Dickinson And Company | Flush syringe with flip cap |
US10871246B2 (en) | 2018-01-30 | 2020-12-22 | Becton, Dickinson And Company | Universal connector or cap for male and female threaded fittings |
JP7444778B2 (ja) * | 2018-02-02 | 2024-03-06 | ベクトン・ディキンソン・アンド・カンパニー | シリンジアセンブリ |
US11273298B2 (en) | 2018-04-10 | 2022-03-15 | Becton, Dickinson And Company | Universal single-use cap for male and female connectors |
US11083840B2 (en) * | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
USD903864S1 (en) | 2018-06-20 | 2020-12-01 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
JP1630477S (ja) | 2018-07-06 | 2019-05-07 | ||
CA3109846A1 (en) * | 2018-09-07 | 2020-03-12 | Becton, Dickinson And Company | Syringe assembly and adapter member |
IT201800009269A1 (it) | 2018-10-09 | 2020-04-09 | Paolo Gobbi Frattini Srl | Adattatore maschio-femmina per connettore a chiusura ermetica, perforabile con innesto maschio ed automaticamente richiudibile a tenuta, particolarmente per dispositivi di contenimento ed erogazione di soluzioni liquide ad uso farmacologico e/o nutrizionale, e connettore ad innesto maschio munito di adattatore maschio-femmina. |
USD923812S1 (en) | 2019-01-16 | 2021-06-29 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
US11964137B2 (en) * | 2019-01-16 | 2024-04-23 | Boston Scientific Scimed, Inc. | Cryotherapeutic delivery device |
JP1648075S (ja) | 2019-01-17 | 2019-12-16 | ||
US11511100B2 (en) | 2019-01-30 | 2022-11-29 | Becton, Dickinson And Company | Universal cap for male and female connectors |
JP7101900B2 (ja) | 2019-01-31 | 2022-07-15 | ウェスト・ファーマ・サービシーズ・アイエル・リミテッド | 液体移送装置 |
WO2020222220A1 (en) | 2019-04-30 | 2020-11-05 | West Pharma. Services IL, Ltd. | Liquid transfer device with dual lumen iv spike |
US20220362482A1 (en) | 2019-10-08 | 2022-11-17 | Becton Dickinson France | Connector for Connecting a Medical Injection Device to a Container and Assembly Comprising Said Connector and Medical Injection Device |
US11975168B2 (en) | 2019-11-18 | 2024-05-07 | Becton, Dickinson And Company | Disinfectant cap |
US11857753B2 (en) | 2019-12-23 | 2024-01-02 | Becton, Dickinson And Company | Disinfecting syringe tip |
US11890445B2 (en) | 2019-12-23 | 2024-02-06 | Becton, Dickinson And Company | Universal disinfection cap |
US12029828B2 (en) | 2020-03-05 | 2024-07-09 | Becton, Dickinson And Company | Disinfection cap |
DE102020202939A1 (de) | 2020-03-06 | 2021-09-09 | B. Braun Melsungen Aktiengesellschaft | Kupplungselement für ein geschlossenes Fluidtransfersystem, Gegenkupplungselement für ein solches Kupplungselement sowie Kupplungssystem |
DE102020202935A1 (de) | 2020-03-06 | 2021-09-09 | B. Braun Melsungen Aktiengesellschaft | Kupplungselement für ein geschlossenes Fluidtransfersystem, Gegenkupplungselement für ein solches Kupplungselement sowie Kupplungssystem |
US11969572B2 (en) | 2020-04-17 | 2024-04-30 | Becton, Dickinson And Company | Disinfection cap |
US11890446B2 (en) | 2020-04-17 | 2024-02-06 | Becton, Dickinson And Company | Cap for male and female threaded fittings |
US12005223B2 (en) | 2020-04-17 | 2024-06-11 | Becton, Dickinson And Company | Disinfection cap |
USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
DE102021203488A1 (de) * | 2021-04-08 | 2022-10-13 | B. Braun Melsungen Aktiengesellschaft | Adaptervorrichtung |
USD1010112S1 (en) | 2021-07-03 | 2024-01-02 | KAIRISH INNOTECH Private Ltd. | Vial adapter with valve |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US527958A (en) * | 1894-10-23 | The norhij pcters co | ||
US3882909A (en) * | 1973-07-05 | 1975-05-13 | Ims Ltd | Trans-a-jet 1 |
US4128098A (en) * | 1976-12-06 | 1978-12-05 | American Hospital Supply Corporation | Valved spike transfer device |
FR2390202A1 (fr) * | 1977-05-11 | 1978-12-08 | Anvar | Procede et dispositif de traitement d'un produit se presentant sous forme de grains et application a la torrefaction |
IT1173370B (it) * | 1984-02-24 | 1987-06-24 | Erba Farmitalia | Dispositivo di sicurezza per collegare una siringa alla imboccatura di un flacone contenente un farmaco o di un tubicino per l'erogazione del farmaco della siringa |
US4662878A (en) * | 1985-11-13 | 1987-05-05 | Patents Unlimited Ltd. | Medicine vial adaptor for needleless injector |
US4631057A (en) * | 1985-12-17 | 1986-12-23 | Dolores A. Smith | Shielded needle |
US4886499A (en) * | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
IT1231892B (it) * | 1987-10-14 | 1992-01-15 | Farmitalia Carlo Erba S P A Mi | Apparecchio con organi di bloccaggio di sicurezza per il collegamento di una siringa ad un flacone contenente un farmaco |
US5211638A (en) * | 1988-01-25 | 1993-05-18 | Baxter International Inc. | Pre-slit injection site |
US4973310A (en) * | 1988-12-30 | 1990-11-27 | Becton, Dickinson And Company | Single-use syringe |
US4944736A (en) * | 1989-07-05 | 1990-07-31 | Holtz Leonard J | Adaptor cap for centering, sealing, and holding a syringe to a bottle |
US5125908A (en) * | 1990-10-19 | 1992-06-30 | Cohen Milton J | Hypodermic syringe with protective holder |
US5527288A (en) * | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
US5338310A (en) * | 1992-02-06 | 1994-08-16 | Becton, Dickinson And Company | Needle device having safety indication features |
US5328483A (en) * | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US5279582A (en) * | 1992-04-01 | 1994-01-18 | Thomas R Davison | Retractable syringe sheath with bottle engagement |
US5279576A (en) * | 1992-05-26 | 1994-01-18 | George Loo | Medication vial adapter |
US5279583A (en) * | 1992-08-28 | 1994-01-18 | Shober Jr Robert C | Retractable injection needle assembly |
US5344417A (en) * | 1992-09-11 | 1994-09-06 | Becton, Dickinson And Company | Universal fitting for inoculation receptacles |
US5360408A (en) * | 1992-11-16 | 1994-11-01 | Vaillancourt Vincent L | Shielded hypodermic needle assembly and a shield assembly for a hypodermic needle |
US5385555A (en) * | 1993-01-08 | 1995-01-31 | Becton, Dickinson And Company | Lockable safety shield for hypodermic syringe |
US5356406A (en) * | 1993-01-08 | 1994-10-18 | Steven Schraga | Adaptor to facilitate interconnection of medicine bottle and syringe |
SE9400282L (sv) * | 1994-01-28 | 1995-07-29 | Cme Blasting & Mining Equip | Hållaranordning |
US5526306A (en) * | 1994-02-10 | 1996-06-11 | Mega Chips Corporation | Semiconductor memory device and method of fabricating the same |
US5527306A (en) * | 1994-04-18 | 1996-06-18 | Haining; Michael L. | Vial adapter |
IL114960A0 (en) * | 1995-03-20 | 1995-12-08 | Medimop Medical Projects Ltd | Flow control device |
WO1997002853A1 (fr) * | 1995-07-11 | 1997-01-30 | Debiotech S.A. | Percuteur de perfusion |
US5893397A (en) * | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
FR2753624B1 (fr) * | 1996-09-25 | 1999-04-16 | Biodome | Dispositif de connexion, en particulier entre un recipient avec bouchon perforable et une seringue |
GB9701413D0 (en) * | 1997-01-24 | 1997-03-12 | Smithkline Beecham Biolog | Novel device |
US5954104A (en) * | 1997-02-28 | 1999-09-21 | Abbott Laboratories | Container cap assembly having an enclosed penetrator |
US5772652A (en) * | 1997-05-14 | 1998-06-30 | Comar, Inc. | Stab cap for a vial having a puncturable seal |
US5925029A (en) * | 1997-09-25 | 1999-07-20 | Becton, Dickinson And Company | Method and apparatus for fixing a connector assembly onto a vial with a crimp cap |
US6019750A (en) * | 1997-12-04 | 2000-02-01 | Baxter International Inc. | Sliding reconstitution device with seal |
US6378714B1 (en) * | 1998-04-20 | 2002-04-30 | Becton Dickinson And Company | Transferset for vials and other medical containers |
US6358236B1 (en) * | 1998-08-06 | 2002-03-19 | Baxter International Inc. | Device for reconstituting medicaments for injection |
FR2783808B1 (fr) * | 1998-09-24 | 2000-12-08 | Biodome | Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif |
ATE318924T1 (de) * | 1998-12-04 | 2006-03-15 | Univ Manitoba | Zwei-schritte-verfahren zur impfung gegen chlamydia |
FR2789369B1 (fr) * | 1999-02-10 | 2001-04-27 | Biodome | Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif |
US6843781B2 (en) * | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
US6494865B1 (en) * | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
US6569123B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Prefillable intradermal injector |
US20020193740A1 (en) * | 1999-10-14 | 2002-12-19 | Alchas Paul G. | Method of intradermally injecting substances |
US6569143B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Method of intradermally injecting substances |
US6776776B2 (en) * | 1999-10-14 | 2004-08-17 | Becton, Dickinson And Company | Prefillable intradermal delivery device |
US6139534A (en) * | 2000-01-24 | 2000-10-31 | Bracco Diagnostics, Inc. | Vial access adapter |
WO2001060436A1 (en) * | 2000-02-15 | 2001-08-23 | Comar, Inc. | Needleless access apparatus and system |
US6656433B2 (en) * | 2001-03-07 | 2003-12-02 | Churchill Medical Systems, Inc. | Vial access device for use with various size drug vials |
GB0118419D0 (en) * | 2001-07-28 | 2001-09-19 | Owen Mumford Ltd | Improvements relating to injection devices |
US6715520B2 (en) * | 2001-10-11 | 2004-04-06 | Carmel Pharma Ab | Method and assembly for fluid transfer |
ES2262733T3 (es) * | 2001-12-17 | 2006-12-01 | Bristol-Myers Squibb Company | Dispositivo de transferencia y sistema que comprende un conjunto de tapa, un recipiente y el dispositivo de transferencia. |
US6875205B2 (en) * | 2002-02-08 | 2005-04-05 | Alaris Medical Systems, Inc. | Vial adapter having a needle-free valve for use with vial closures of different sizes |
USD495416S1 (en) * | 2003-05-30 | 2004-08-31 | Alaris Medical Systems, Inc. | Vial access device |
IL161660A0 (en) | 2004-04-29 | 2004-09-27 | Medimop Medical Projects Ltd | Liquid drug delivery device |
-
2006
- 2006-03-13 US US11/374,488 patent/US20070060904A1/en not_active Abandoned
- 2006-03-14 CA CA 2600590 patent/CA2600590C/en active Active
- 2006-03-14 WO PCT/US2006/009198 patent/WO2006099441A2/en active Application Filing
- 2006-03-14 MX MX2007011239A patent/MX2007011239A/es active IP Right Grant
- 2006-03-14 AT AT06738279T patent/ATE489066T1/de not_active IP Right Cessation
- 2006-03-14 DE DE200660018426 patent/DE602006018426D1/de active Active
- 2006-03-14 EP EP06738279A patent/EP1858474B1/en active Active
- 2006-03-14 AU AU2006223047A patent/AU2006223047B2/en active Active
- 2006-03-14 BR BRPI0609008A patent/BRPI0609008B8/pt active IP Right Grant
- 2006-03-14 JP JP2008501979A patent/JP5026405B2/ja active Active
-
2009
- 2009-08-07 US US12/537,497 patent/US8262641B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DE602006018426D1 (de) | 2011-01-05 |
US20090299325A1 (en) | 2009-12-03 |
AU2006223047A1 (en) | 2006-09-21 |
EP1858474A2 (en) | 2007-11-28 |
US8262641B2 (en) | 2012-09-11 |
CA2600590A1 (en) | 2006-09-21 |
WO2006099441A2 (en) | 2006-09-21 |
BRPI0609008B1 (pt) | 2021-01-12 |
MX2007011239A (es) | 2007-10-18 |
CA2600590C (en) | 2014-02-04 |
AU2006223047B2 (en) | 2011-11-17 |
WO2006099441A3 (en) | 2006-11-30 |
BRPI0609008A2 (pt) | 2010-01-12 |
BRPI0609008B8 (pt) | 2021-06-22 |
EP1858474B1 (en) | 2010-11-24 |
JP2008532701A (ja) | 2008-08-21 |
ATE489066T1 (de) | 2010-12-15 |
US20070060904A1 (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5026405B2 (ja) | 短針を有する注射器のための充填システムおよび方法 | |
US7083599B2 (en) | Prefillable intradermal delivery device | |
AU2007203540B2 (en) | Prefillable intradermal delivery device | |
EP1722843B1 (en) | Intradermal syringe and needle assembly | |
EP1379299B1 (en) | Prefillable intradermal injector | |
CN101166504B (zh) | 具有短针头的注射器的填装***和方法 | |
JP4764593B2 (ja) | 予め充填可能な皮内送出装置 | |
ZA200307923B (en) | Prefillable intradermal delivery device. | |
AU2001257048A1 (en) | Prefillable intradermal delivery device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090217 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110506 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110512 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110808 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110815 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110906 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110913 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111006 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111014 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111101 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120525 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120620 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150629 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5026405 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |